Welcome to our dedicated page for Fuller H B Co SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The H.B. Fuller Company (NYSE: FUL) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. H.B. Fuller is a Minnesota-based issuer that describes itself as the largest pureplay adhesives company in the world, focused on adhesives, sealants, functional coatings and other chemical-based products.
Investors can use this page to access current and historical Forms 8‑K, which H.B. Fuller files to report material events such as quarterly and annual earnings releases, dividend declarations and board changes. Recent 8‑K filings referenced in the input include items under Item 2.02 – Results of Operations and Financial Condition and Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers, along with exhibits that attach the related press releases.
In addition to event-driven reports, users can review the company’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q (when available in the feed). These filings typically provide detailed information on net revenue, margins, net income, cash flow, segment performance, risk factors and other disclosures that complement the non‑GAAP metrics discussed in earnings releases and Regulation G reconciliation tables.
Stock Titan’s platform enhances these documents with AI-powered summaries that explain key sections of lengthy filings, highlight important changes from prior periods and clarify technical language. Real-time updates from EDGAR ensure that new H.B. Fuller filings appear promptly, while links to exhibits make it easier to connect narrative disclosures with supporting press releases and financial tables.
For users researching FUL, this page offers a focused view of H.B. Fuller’s regulatory history, from material event 8‑Ks to periodic reports, helping readers understand how the adhesives manufacturer describes its operations, financial condition, governance and risk profile in formal SEC documents.
H.B. Fuller Senior VP Malik Muhammad Shahbaz reported routine equity compensation activity. On January 27, 2026, 600 restricted stock units converted into common stock at $59.81 per share. The filing notes that 192 of the resulting shares were withheld to cover taxes due on the 600 shares issued.
After these transactions, Shahbaz directly beneficially owned 13,697 shares of common stock, which include shares acquired through a dividend reinvestment plan. He also held multiple employee stock options that are either fully vested or vest over time, and additional restricted stock units that convert into common stock on a 1‑for‑1 basis.
H.B. Fuller senior vice president Laura J. Lorenz reported equity compensation activity involving restricted stock units and common shares. On January 27, 2026, she exercised 1,020 restricted stock units and another 600 units, each converting 1-for-1 into common stock at an exercise price of $59.81 per share.
To cover taxes on these issuances, 217 and 367 common shares were withheld, leaving her with 1,036 directly held common shares. She also continues to hold employee stock options for 14,052 and 10,237 shares and 2,072 additional restricted stock units that vest in three annual installments.
H.B. Fuller Executive Vice President James J. East reported equity transactions dated 01/27/2026. He exercised 870 restricted stock units at $59.81 per share into common stock, then had 192 shares withheld to cover taxes, as noted in the footnotes.
After these transactions, East directly owned 5,858 shares of common stock and an additional 106.19 shares indirectly through a 401(k) plan. He also reported holdings of various employee stock options, phantom units, and restricted stock units that generally convert into or are exercisable for H.B. Fuller common stock on a 1-for-1 basis, subject to stated vesting schedules.
H.B. Fuller senior vice president of global R&D Du Xinyu reported routine equity compensation activity. On 01/27/2026, 448 restricted stock units converted into common shares at $59.81, increasing directly held common stock to 3,215 shares before tax withholding.
A separate transaction shows 134 shares of common stock withheld for taxes due on the 448 shares issued, leaving 3,081 common shares directly owned. The filing also lists multiple employee stock option grants and additional restricted stock units with specified vesting schedules and expiration dates.
H.B. Fuller Executive VP and CFO John J. Corkrean reported routine equity compensation activity. On January 27, 2026, 1,441 restricted stock units were converted into common shares at $59.81 per share, increasing his directly held common stock before tax withholding.
On the same date, 442 common shares were withheld to cover taxes on the shares issued, leaving him with 59,508 directly owned common shares. He also continues to hold various fully vested and time-vesting employee stock options, restricted stock units, and phantom units that are each tied to H.B. Fuller common stock on a 1-for-1 basis.
H.B. Fuller senior vice president Heather Campe reported routine equity compensation activity. On January 27, 2026, 634 restricted stock units converted into common stock at an exercise price of $59.81 per share. To cover taxes on these shares, 161 common shares were withheld, as noted in the footnotes.
After these transactions, Campe directly held 24,653.0782 shares of H.B. Fuller common stock. She also held various employee stock options, phantom units and additional restricted stock units that generally vest over time or are already 100% vested, all on a 1-for-1 basis into common stock under the company’s plans.
H.B. Fuller executive Nathan D. Weaver reported multiple equity compensation transactions. On January 26, 2026, he received an award of 23,187 employee stock options with an exercise price of $59.81 per share, vesting in three annual installments starting on that date.
Weaver also acquired 3,420 restricted stock units (RSUs) that convert into common stock on a 1‑for‑1 basis and vest over three annual installments beginning January 26, 2027. Separately, 555 RSUs were exercised into common shares at $60.07, and 192 shares were withheld to cover taxes, leaving 11,137 common shares held directly. The filing lists additional previously granted, fully vested stock options, phantom units, and RSUs that remain outstanding.
H.B. Fuller director Martin Celine Christine reported an equity grant of 1,300 restricted stock units (RSUs) on January 26, 2026. The RSUs have an exercise price of $0.0000 and convert into common shares on a 1-for-1 basis.
The RSUs vest in three annual installments of 33%, 33%, and 34%, beginning on January 26, 2027, and are held as direct ownership. After this grant, the director beneficially owns 1,300 derivative securities linked to H.B. Fuller common stock.
H.B. Fuller senior vice president, general counsel and corporate secretary Gregory O. Ogunsanya reported routine equity compensation activity. On January 26, 2026, he received an employee stock option for 16,863 shares of common stock with an exercise price of
On the same date, 506 restricted stock units vested and were converted into the same number of common shares at
H.B. Fuller Company executive Laura J. Lorenz, Sr. VP, HR & Communication, reported new equity awards. On January 26, 2026 she received an employee stock option grant for 14,052 options at an exercise price of $59.81 per share, vesting in three annual installments of 33%, 33%, and 34% beginning on that date and expiring on January 26, 2036.
She was also granted 2,072 restricted stock units (RSUs) that convert into common stock on a 1-for-1 basis and vest in three annual installments on the same schedule. The filing also lists previously held awards, including 10,237 stock options and RSU balances of 1,020.01 and 1,820.56 units, which include amounts acquired through a dividend equivalent reinvestment feature. All positions are reported as directly owned.